From July 9 to 13, the 32nd China Lanzhou Investment and Trade Fair (Lanzhou Fair) was held at Gansu International Convention & Exhibition Center. Under the theme "New Opportunities for Pragmatic Cooperation, New Pattern for Open Development," the fair covered an exhibition area of 54,000 square meters and brought together more than 1,900 exhibitors from 30 countries and regions. UnicornShell showcased its plant-based capsules and modernized TCM medicine-food homology product series, presenting the company's technological breakthroughs and industrialization achievements in plant-based pharmaceutical excipients and innovative TCM formulations.

Director Liang Cheng of Dingxi Agriculture and Rural Bureau visits booth, focusing on medicine-food homology cooperation

During the fair, Director Liang Cheng and his delegation from the Dingxi Agriculture and Rural Bureau visited the UnicornShell booth to learn about the progress of the company's plant-based capsule project and its product lineup of modernized TCM medicine-food homology series. Director Liang expressed strong interest in UnicornShell's strategy of deeply integrating plant-based capsule technology with TCM modernization and developing medicine-food homology products. He sincerely invited UnicornShell to participate in the Dingxi Potato Conference and expressed hope for in-depth cooperation in TCM deep processing, medicine-food homology product development, and related fields.

Wuwei Daily and Wuwei Integrated Media Center report on booth, highlighting new pharma industry and key projects

As one of the four featured theme cities of this year's Lanzhou Fair, Wuwei attracted wide attention. Journalists from Wuwei Daily and the Wuwei Integrated Media Center visited the UnicornShell booth to film and report on the company's plant-based capsules and modernized TCM medicine-food homology products, reflecting media attention to the new pharmaceutical industry and emphasis on Wuwei's key industrial projects.

27 years of plant-based capsule R&D: UnicornShell enters the global first tier

Since launching plant-based capsule research in 1999, UnicornShell has spent 27 years building an intellectual property portfolio of more than 30 assets, including national invention patents, international invention patents, utility model patents, and software copyrights. Its core plant-based empty capsules have obtained U.S. FDA certification, Halal certification, Kosher certification, European BRC certification, and China NMPA associated review registration. In May 2026, the company extended the shelf life of its plant-based empty capsules to 60 months, and the relevant change filing was completed with the Center for Drug Evaluation (CDE) of China's National Medical Products Administration, marking that domestic plant-based empty capsules have entered the global first tier in stability research.

The 32nd Lanzhou Fair provided UnicornShell with an important platform to present innovative results, deepen government-enterprise cooperation, and expand market opportunities. Moving forward, the company will continue to focus on plant-based pharmaceutical excipients and innovative TCM formulations, accelerate its nationwide production capacity layout, and contribute to the high-quality development of China's plant-based capsule industry and the modernization of TCM.